{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T01:01:56Z","timestamp":1793581316171,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:00:00Z","timestamp":1542931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00066-018-1404-1","type":"journal-article","created":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T15:19:37Z","timestamp":1542986377000},"page":"265-273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Biliary duct stenosis after image-guided high-dose-rate interstitial brachytherapy of central and hilar liver tumors","Gallengangstenosen nach bildgef\u00fchrter interstitieller Hochdosis-Brachytherapie zentraler und hilusnaher Lebertumore"],"prefix":"10.1007","volume":"195","author":[{"given":"Maciej","family":"Powerski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Penzlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricarda","family":"Seidensticker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Mohnike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Damm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Steffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Pech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnther","family":"Gademann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Ricke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Seidensticker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,23]]},"reference":[{"key":"1404_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12957-015-0497-6","volume":"13","author":"I-M Kuo","year":"2015","unstructured":"Kuo I\u2011M, Huang S\u2011F, Chiang J\u2011M et al (2015) Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis. World J Surg Oncol 13:92. \n                    https:\/\/doi.org\/10.1186\/s12957-015-0497-6","journal-title":"World J Surg Oncol"},{"key":"1404_CR2","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1093\/annonc\/mds236","volume":"23","author":"HJ Schmoll","year":"2012","unstructured":"Schmoll HJ, Van Cutsem E, Stein A et\u00a0al (2012) ESMO consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann Oncol 23:2479\u20132516. \n                    https:\/\/doi.org\/10.1093\/annonc\/mds236","journal-title":"Ann Oncol"},{"key":"1404_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s12328-017-0778-4","volume":"10","author":"M Fukasawa","year":"2017","unstructured":"Fukasawa M, Takano S, Shindo H et\u00a0al (2017) Endoscopic biliary stenting for unresectable malignant hilar obstruction. Clin J Gastroenterol 10:485\u2013490. \n                    https:\/\/doi.org\/10.1007\/s12328-017-0778-4","journal-title":"Clin J Gastroenterol"},{"key":"1404_CR4","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1007\/s00066-017-1128-7","volume":"193","author":"Y Cho","year":"2017","unstructured":"Cho Y, Kim TH, Seong J (2017) Improved oncologic outcome with chemoradiotherapy followed by surgery in unresectable intrahepatic cholangiocarcinoma. Strahlenther Onkol 193:620\u2013629. \n                    https:\/\/doi.org\/10.1007\/s00066-017-1128-7","journal-title":"Strahlenther Onkol"},{"key":"1404_CR5","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ejrad.2006.03.007","volume":"59","author":"Y Kim","year":"2006","unstructured":"Kim Y, Rhim H, Cho OK et\u00a0al (2006) Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors. Eur J Radiol 59:432\u2013441. \n                    https:\/\/doi.org\/10.1016\/j.ejrad.2006.03.007","journal-title":"Eur J Radiol"},{"key":"1404_CR6","doi-asserted-by":"publisher","first-page":"e410","DOI":"10.1111\/j.1440-1746.2007.05091.x","volume":"23","author":"T Ohnishi","year":"2008","unstructured":"Ohnishi T, Yasuda I, Nishigaki Y et\u00a0al (2008) Intraductal chilled saline perfusion to prevent bile duct injury during percutaneous radiofrequency ablation for hepatocellular carcinoma. J\u00a0Gastroenterol Hepatol 23:e410\u2013e415. \n                    https:\/\/doi.org\/10.1111\/j.1440-1746.2007.05091.x","journal-title":"J Gastroenterol Hepatol"},{"key":"1404_CR7","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/BF02303482","volume":"5","author":"MS Kahlenberg","year":"1998","unstructured":"Kahlenberg MS, Volpe C, Klippenstein DL et\u00a0al (1998) Clinicopathologic effects of cryotherapy on hepatic vessels and bile ducts in a\u00a0porcine model. Ann Surg Oncol 5:713\u2013718","journal-title":"Ann Surg Oncol"},{"key":"1404_CR8","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.5754\/hge121142","volume":"60","author":"Y-Z Huang","year":"2013","unstructured":"Huang Y\u2011Z, Zhou S\u2011C, Zhou H, Tong M (2013) Radiofrequency ablation versus cryosurgery ablation for hepatocellular carcinoma: a\u00a0meta-analysis. Hepatogastroenterology 60:1131\u20131135. \n                    https:\/\/doi.org\/10.5754\/hge121142","journal-title":"Hepatogastroenterology"},{"key":"1404_CR9","doi-asserted-by":"publisher","first-page":"e509","DOI":"10.1016\/j.ejrad.2013.04.046","volume":"82","author":"F Collettini","year":"2013","unstructured":"Collettini F, Singh A, Schnapauff D et al (2013) Computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of metastases adjacent to the liver hilum. Eur J Radiol 82:e509\u2013e514. \n                    https:\/\/doi.org\/10.1016\/j.ejrad.2013.04.046","journal-title":"Eur J Radiol"},{"key":"1404_CR10","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1097\/01.RVI.0000141343.43441.06","volume":"15","author":"J Ricke","year":"2004","unstructured":"Ricke J, Wust P, Wieners G et al (2004) Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation. J\u00a0Vasc Interv Radiol 15:1279\u20131286. \n                    https:\/\/doi.org\/10.1097\/01.RVI.0000141343.43441.06","journal-title":"J Vasc Interv Radiol"},{"key":"1404_CR11","first-page":"3368","volume":"12","author":"J Grimm","year":"2011","unstructured":"Grimm J, LaCouture T, Croce R et\u00a0al (2011) Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy. J\u00a0Appl Clin Med Phys 12:3368","journal-title":"J Appl Clin Med Phys"},{"key":"1404_CR12","volume-title":"CTCAE v4.03","author":"National Cancer Institute","year":"2009","unstructured":"National Cancer Institute (2009) CTCAE v4.03. \n                    https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm#ctc_50\n                    \n                  . Accessed 17 July 2018"},{"key":"1404_CR13","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ijrobp.2014.11.028","volume":"91","author":"EC Osmundson","year":"2015","unstructured":"Osmundson EC, Wu Y, Luxton G et\u00a0al (2015) Predictors of toxicity associated with stereotactic body radiation therapy to the central hepatobiliary tract. Int J Radiat Oncol Biol Phys 91:986\u2013994. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2014.11.028","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1404_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.radonc.2016.10.024","volume":"122","author":"DAS Toesca","year":"2017","unstructured":"Toesca DAS, Osmundson EC, von Eyben R et\u00a0al (2017) Central liver toxicity after SBRT: an expanded analysis and predictive nomogram. Radiother Oncol 122:130\u2013136. \n                    https:\/\/doi.org\/10.1016\/j.radonc.2016.10.024","journal-title":"Radiother Oncol"},{"key":"1404_CR15","unstructured":"EQD2 and BED calculator. \n                    http:\/\/eqd2.com\n                    \n                  . Accessed 17 July 2018"},{"key":"1404_CR16","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","volume":"62","author":"JF Fowler","year":"1989","unstructured":"Fowler JF (1989) The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62:679\u2013694. \n                    https:\/\/doi.org\/10.1259\/0007-1285-62-740-679","journal-title":"Br J Radiol"},{"key":"1404_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s00066-004-1179-4","volume":"180","author":"J Ricke","year":"2004","unstructured":"Ricke J, Wust P, Stohlmann A et al (2004) CT-guided brachytherapy. A novel percutaneous technique for interstitial ablation of liver metastases. Strahlenther Onkol 180:274\u2013280. \n                    https:\/\/doi.org\/10.1007\/s00066-004-1179-4","journal-title":"Strahlenther Onkol"},{"key":"1404_CR18","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s00066-017-1120-2","volume":"193","author":"K Mohnike","year":"2017","unstructured":"Mohnike K, Neumann K, Hass P et al (2017) Radioablation of adrenal gland malignomas with interstitial high-dose-rate brachytherapy\u202f: efficacy and outcome. Strahlenther Onkol 193:612\u2013619. \n                    https:\/\/doi.org\/10.1007\/s00066-017-1120-2","journal-title":"Strahlenther Onkol"},{"key":"1404_CR19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ijrobp.2009.09.026","volume":"78","author":"J Ricke","year":"2010","unstructured":"Ricke J, Mohnike K, Pech M et al (2010) Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 78:479\u2013485. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2009.09.026","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1404_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ijrobp.2009.07.1700","volume":"78","author":"K Mohnike","year":"2010","unstructured":"Mohnike K, Wieners G, Schwartz F et al (2010) Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival. Int J Radiat Oncol Biol Phys 78:172\u2013179. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2009.07.1700","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1404_CR21","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.ijrobp.2006.02.052","volume":"65","author":"F Streitparth","year":"2006","unstructured":"Streitparth F, Pech M, B\u00f6hmig M et al (2006) In vivo assessment of the gastric mucosal tolerance dose after single fraction, small volume irradiation of liver malignancies by computed tomography-guided, high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 65:1479\u20131486. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2006.02.052","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1404_CR22","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1007\/s00330-013-2816-z","volume":"23","author":"N Tselis","year":"2013","unstructured":"Tselis N, Chatzikonstantinou G, Kolotas C et al (2013) Computed tomography-guided interstitial high dose rate brachytherapy for centrally located liver tumours: a\u00a0single institution study. Eur Radiol 23:2264\u20132270. \n                    https:\/\/doi.org\/10.1007\/s00330-013-2816-z","journal-title":"Eur Radiol"},{"key":"1404_CR23","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.ijrobp.2012.09.012","volume":"85","author":"T Eriguchi","year":"2013","unstructured":"Eriguchi T, Takeda A, Sanuki N et\u00a0al (2013) Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system. Int J Radiat Oncol Biol Phys 85:1006\u20131011. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2012.09.012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1404_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4291\/wjgp.v9.i1.1","volume":"9","author":"M Ahmed","year":"2018","unstructured":"Ahmed M (2018) Acute cholangitis\u2014an update. World J Gastrointest Pathophysiol 9:1\u20137. \n                    https:\/\/doi.org\/10.4291\/wjgp.v9.i1.1","journal-title":"World J Gastrointest Pathophysiol"},{"key":"1404_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5582\/bst.2016.01033","volume":"10","author":"Z Sun","year":"2016","unstructured":"Sun Z, Zhu Y, Zhu B et\u00a0al (2016) Controversy and progress for treatment of acute cholangitis after Tokyo Guidelines (TG13). Biosci Trends 10:22\u201326. \n                    https:\/\/doi.org\/10.5582\/bst.2016.01033","journal-title":"Biosci Trends"},{"key":"1404_CR26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1055\/s-2007-1007122","volume":"19","author":"JM Llovet","year":"1999","unstructured":"Llovet JM, Br\u00fa C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329\u2013338. \n                    https:\/\/doi.org\/10.1055\/s-2007-1007122","journal-title":"Semin Liver Dis"},{"key":"1404_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1470-2045(12)70477-1","volume":"14","author":"J Bennouna","year":"2013","unstructured":"Bennouna J, Sastre J, Arnold D et\u00a0al (2013) Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a\u00a0randomised phase 3 trial. Lancet Oncol 14:29\u201337. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(12)70477-1","journal-title":"Lancet Oncol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-018-1404-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-018-1404-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-018-1404-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T00:06:23Z","timestamp":1574467583000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-018-1404-1"}},"subtitle":["A\u00a0systematic analysis of 102 cases","Eine systematische Analyse von 102 F\u00e4llen"],"short-title":[],"issued":{"date-parts":[[2018,11,23]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1404"],"URL":"https:\/\/doi.org\/10.1007\/s00066-018-1404-1","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,23]]},"assertion":[{"value":"17 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.\u00a0Powerski, S.\u00a0Penzlin, P.\u00a0Hass, R.\u00a0Seidensticker, K.\u00a0Mohnike, R.\u00a0Damm, I.\u00a0Steffen, M.\u00a0Pech, G.\u00a0Gademann, J.\u00a0Ricke, and M.\u00a0Seidensticker declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}